We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.10 | -2.30% | 4.25 | 4.00 | 4.50 | 4.35 | 4.25 | 4.35 | 372,801 | 16:24:58 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -10.12 | 22.67M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/12/2016 11:41 | But of course as Livingbridge have already done their DD here you ate already fine with it | quazie12 | |
22/12/2016 11:39 | SuperHave a proper look back at that TT transaction its all there at Companies House. | quazie12 | |
22/12/2016 07:10 | Q12 Strongly worded but not legal language like 'wilfully blind'. Keeping out of the swing as per usual. Not the actions of a confident man. Monotonous Vendetta Heavy analysis. Blue skies await supersonico. | supersonico | |
22/12/2016 05:42 | The 500k trade at 14p+ yesterday am must be hurting someone. 20% loss in a day ! Anyways I look forward to gem's rebuttal today of TW's strongly worded post on sharepuppets. I agree with pretty much all of it esp the TT valuation. One thing for sure the auditors are in a bit of a bind now with that. they valued the "asset" for that transaction with a very opaque basis of valuation in the Companies House lodging and I have been looking into the possibility of going after them for my loss on the basis that shareholders should be protected when a limited co uses shares to acquire "assets." I will keep you posted over the coming months on that front.RegardsQ12 | quazie12 | |
21/12/2016 17:50 | Q12, What do you make of these multiple £44k £72K £73K trades? | supersonico | |
21/12/2016 15:50 | Q12 I think you will find that the main reason folk get 'obsessed' about Frothy is his analysis is Vendetta weighted against M Walters and K Brooks and light on the real progress Eden are making. Eastman a massive NYSE company, Sipcam another Global player, LivingBridge and Shore Cap etal all disagree with Frothy on everything he says about both TT and the efficacy of the technology but he persists. How can anyone take him seriously when he describes Eden Tech as Fraudulent when it is validated by Global billion dollar companies... If he really was convinced of his case he would be describing Shore Cap as 'Wilfully blind'. He's not which speaks volumes. Blue skies still await Supersonico | supersonico | |
21/12/2016 13:16 | Not just today Q12, but over the past few weeks. over £300k I couldn't make that up just look at the recent rise and the continued buying today .. ..eh Blue skies await Supersonico | supersonico | |
21/12/2016 12:57 | How on earth can sales be ahead of that forecast by partners but not according to the company broker. Super decides some institution has been buying in today and Fafa thinks it would have been beneficial somehow to hold the bad news back until the NY. Couldn't really make it up. Ostriches abound SK Eh ? | quazie12 | |
21/12/2016 12:36 | Looking forward to finding out which Institution has been buying over the last few weeks and continues to buy today. | supersonico | |
21/12/2016 11:56 | Sums things up pretty well. How much revenue did Shore Cap factor into their forecasts and valuation for this year? From memory it was over £900k and what have they achieved - less than half of that. No great surprise to me | sweet karolina | |
21/12/2016 08:45 | What a disaster for Christmas with this share price drop at 16%. Why can Eden issue the update trade after new year giving LT shareholders some joy just for a few days. Are they clever or silly? | fafa48 | |
21/12/2016 07:09 | A bit mixed. A profit warning and a deal. Probably need to raise some cash in H2 next year but finally starting to trend in the right direction. | monty panesar | |
20/12/2016 13:52 | Wonder and Temerity | supersonico | |
20/12/2016 12:52 | Yes M, I will be including the moment Frothy realised Shore Cap were the new Nomad..that is after missing that small detail. And yes P, I will be reliving the boycast moment where Frothy cried when he realised LivingBridge were involved and had a great reputation for DD, that was indeed comedy Gold as you say. | supersonico | |
20/12/2016 11:52 | Looking forward to writing up the Supersonico triumphant year report. A year when I cleansed this board of the Frothy sycophant and had my own personal boycast. My only disappointment was I was not named as a BB Moron, still you can't have everything, so I'll have to be content with Check Mate Frothy with my Shore Cap Wilfully Blind strategy..or as Frothy prefers in his characteristic cuddly and soft whispering manner..'overlooking ho ho ho ho It's a shame Frothy won't see this as he does not read this site. Blue skies await Supersonico. | supersonico | |
18/12/2016 16:22 | Loving the Alphabetic Spagettio from our 'overlooking' cat toy Looking forward to the 'W' for Wilfully Blind ' for Shore cap ..oh no there just 'overlooking' for 300 plus days as are Livingbridge . Not credible Zero testicles just a 10 year old Walters and Brooks vendetta . Blue sky awaits Supersonico | supersonico | |
16/12/2016 09:42 | Hmmmmm! Looks like the second day of high volume with a rising share price Mind the gap though. | weyweyumfozo | |
08/12/2016 11:42 | Slight tick up today, maybe we are about to get some news | mandatory | |
06/12/2016 19:56 | I see we had a MM 1 share signal on ISDX at 16.03 today. News tomorrow would be nice | supersonico | |
05/12/2016 16:27 | Q12, I certainly would welcome an update on the statements made in the Half yearly report. Sean Smith, Chief Executive Officer of Eden, said: "So far this year, we have seen the first significant commercial sales of 3AEY into the agrochemicals market in Kenya, Greece, Italy and Spain. Whilst the botrytis season is not quite over and, as such, we don't have final sales quantities from our commercial partners for this season, Eden and its partners are very pleased with the sales that have been generated so far. Particularly in Italy where our partner, Sipcam Italia SpA, has invested a significant amount of resource into the commercial launch of "3logy", the brand name they have chosen for 3AEY in that region. "For our nematicide product, negotiations are continuing with a multi-national industry leader, and progress has been made towards a satisfactory conclusion. A final agreement is expected this year covering multiple territories around the world, subject to further negotiations. A number of evaluation projects for both Eden's technologies and products are on-going and I am pleased with the progress that is generally being made, as well as with regulatory progress where territories such as the USA are now being actively pursued. | supersonico | |
05/12/2016 14:49 | SSThe board did a good job getting new money and larger instit shareholders on board, no doubt. Some take comfort from that but what about the bod themselves, £5k shares bought since May 15, its not a lot. I think shareholders are long overdue an update on the various apparent commercial progress in the form of Licencing JVs etc. the 1/2 year statement said very little. You must be getting nervous about the current state of the cash pile. Theres just so little to go on. | quazie12 | |
05/12/2016 08:05 | Hey Q12, It certainly would be good to hear more on sales..agree with you there. It will be interesting to see how the Promotion from Sipcam and the publicity of Awards influenced sales. Looks like we have more II buying recently (repeated £11.5k) which I see as positive. I'm also looking forward to the French ticking some boxes and hearing about Eastman. | supersonico | |
05/12/2016 01:09 | Super your post #1704. Surely you must have thought the company were having a laugh ? That tweet is pretty much their sales update to shareholders for the whole of 2016. PMSLQ12 | quazie12 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions